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RBM4RNA-binding motif protein 4 (RBM4) reportedly reprograms the tissue-speciﬁc splicing network which modu-
lates the development of muscles and pancreatic β-islets. Herein, we report that Rbm4a−/−mice exhibited hy-
perlipidemia accompanied with reduced mass of interscapular brown adipose tissue (iBAT). Elevated RBM4a
led to the isoform shift of IR, Ppar-γ, and Pref-1 genes which play pivotal roles in the different stages of adipogen-
esis. Overexpression of RBM4a enhanced the mitochondrial activity of brown adipocyte-like lineage in the pres-
ence of uncoupling agent. RBM4a-ablated adipocytes inversely exhibited impaired development and inefﬁcient
energy expenditure. Intriguingly, overexpressed RBM4a induced the expression of brown adipocyte-speciﬁc
factors (Prdm16 and Bmp7) in white adipocyte-like lineage, which suggested the potential action of RBM4a on
the white-to-brown trans-differentiation of adipocytes. In differentiating adipocytes, RBM4a constituted a
feed-forward circuit through autoregulating the splicing pattern of its own transcript. Based on these results,
we propose the emerging role of RBM4 in regulating the adipocyte-speciﬁc splicing events and transcription
cascade, which subsequently facilitate the development and function of brown adipocyte-like cells.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Alternative splicing is an important mechanism for regulating gene
expression and expanding proteomic diversity in eukaryotes [1–3].
The meticulous expression of alternatively spliced isoforms is the pre-
dominant means of controlling cell types and functional speciﬁcation
that consequently inﬂuences organogenesis. Exon usage is modulated
by the complex interplay between trans-acting factors and cis-
elements within the alternatively spliced pre-messenger RNA [4]. Over
90% of human genes have been demonstrated to undergo at least one al-
ternative splicing event [5,6], but further investigation is required to de-
cipher the detailed mechanisms involved. Moreover, comprehensive
insights into alternative splicing are indispensable for understanding
the origins of genomic defects.
RNA-binding motif protein 4 (RBM4) is a multifunctional protein
that participates in regulating alternative splicing andmRNA translation
[7–11]. We previously reported that RBM4 modulates the utilization of
alternative exons within several genes which encode muscle and
pancreas-speciﬁc isoforms [7,10]. RBM4 synergizes its effect on
muscle-speciﬁc splicing network by inducing the exon 11-skipped iso-
form of polypyrimidine tract-binding protein (PTB), a myogenicory Science and Biotechnology,
i 11031, Taiwan. Tel.: +886 2
ights reserved.repressor, which is eliminated by nonsense-mediatedmRNAdecay dur-
ing myogenesis [10]. A study with Rbm4 knockout mice shows that
RBM4 also facilitates the development of pancreatic islets [11]. The no-
table augmentation of pancreas-speciﬁc factors, such as Ngn3 and Pdx1,
upon RBM4 overexpression suggests its inﬂuence in promoting pancre-
as development. RBM4 overexpression also induces the alternatively
spliced isoforms of Pax4 and Isl1 which have more-prominent effect
on activating the transcription of insulin gene inβ-islets. Taken together,
RBM4modulates splicing eventswhich in turn inﬂuence organogenesis.
Unbalanced energy homeostasis has led to a substantial rise inworld-
wide incidences of obesity and other metabolic diseases. Obesity is prin-
cipally caused by accumulation of white adipose tissue (WAT), the cells
of which contain a unilocular fat droplet and few mitochondria [12]. In
contrast, brown adipose tissue (BAT) is comprised of multilocular lipid
droplets and abundantmitochondria. The relatively highmetabolic activ-
ity of BAT suggests its therapeutic potential for combating obesity and
metabolic diseases [13]. The canonical BAT shares a developmental origin
with the skeletal muscle, but presumably not with WAT [14]. Classical
brown adipocytes arise fromMyf5-positive progenitors during the pre-
natal development and subsequently populate interscapular BAT
[15,16]. However, so-called beige/brite cells are occasionally found as
abundant clusters in WAT of adult animals which are exposed to a cold
environment. These inducible adipocytes are derived from Myf5-
negative lineages, but have both morphological and biological features
of classical brown adipocytes [17]. A recent study indicated that
platelet-derived growth factor (PDGF) α receptor-positive progenitor
cells isolated from WAT develop into BAT-like cells upon β-adrenergic
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involved in the development of brite cells in terms of fat metabolism.
Adipogenesis is regulated by a complex network involving various
hormones and growth factors [19], of which the insulin signaling plays
a pivotal role in the development of both white and brown adipocytes
[20]. Insulin receptor (IR) substrates act as the docking molecules for
the corresponding hormoneswhich in turn activate downstream signal-
ing pathways [21]. Among them, bone morphogenetic proteins (BMPs)
substantially contribute to the development of distinct adipose tissues
[22]. BMP2 and BMP4 are majorly critical for the commitment step
and complete development of WAT [23–25]. On the other hand, BMP7
has been shown to trigger the development of brown adipocytes from
both committed and uncommitted precursors [26]. BMP7 activates the
expression of PRDM16, the master regulator of BAT development,
which represses the formation of WAT and the skeletal muscle [15,26].
Moreover, BMP7 promotes the activation of p38mitogen-activated pro-
tein kinase (MAPK) pathway which is essential for mitochondrial bio-
genesis in developing BAT [27]. Bmp7 knockout mice inversely exhibit
signiﬁcant paucity of interscapular BAT during embryonic development.
Besides transcription cascade, alternative splicing constitutes another
molecular mechanism which modulates adipocyte development. The
alternative-spliced transcript of Peroxisome proliferator-activated re-
ceptor gamma (Ppar-γ) encodes the adipocyte-speciﬁc isoform, PPAR-
γ2, which is the predominant activator of adipose development [28].
By contrast, the repressive effect of preadipocyte factor 1 (Pref-1) on
adipocyte development is relieved in the relatively high expression of
alternatively spliced isoforms, Pref-1C and Pref-1D [29].
Our work constitutes the ﬁrst demonstration of autoregulated alter-
native splicingwhichmediates the increase in RBM4a during adipogen-
esis. Upregulation of RBM4a subsequently reprograms the adipocyte-
speciﬁc alternative splicing events which exhibit enormous inﬂuence
on promoting adipocyte development in vitro. The upregulated BAT-
related factors in RBM4-overexpressed preadipocytes and the relative
paucity of interscapular BAT in Rbm4a−/−mice both substantiates that
RBM4a could be contributive to the development of BAT.
2. Material and methods
2.1. Serum biochemistry and mice dissection
Male RBM4a−/−mice were generated as previously described [11].
After 8 weeks of feeding a regular diet, mice had access to food and
water for 1 h at the beginning of the dark phase and then were starved
for 8 h. Serum triglyceride (TG) wasmeasured on a Fuji Dri-Chem Clin-
ical Chemistry Analyzer FDC 3500 (housed at the Taiwan Mouse Clinic,
Taipei, Taiwan). After a mouse was euthanized, interscapular fat tissues
were collected, weighed, and immediately frozen at−80 °C until the
RNA and proteins were extracted.
2.2. Cell culture and differentiation
Primary preadipocytes were isolated from the interscapular WAT
and BAT of RBM4a−/− mice and its wild-type littermates. In brief, the
dissected adipose tissues were soaked in HEPES buffer containing type
I collagenase and incubated at 37 °C with gentle shaking for 30 min.
After beingﬁltered through a 25 μmpore-size nylon ﬁlter, the dissociat-
ed cells were collected and cultured in a 12-well plate with pre-warm
DMEM supplemented with 10% (vol/vol) newborn calf serum, 2.4 nM
insulin, 25 μg/ml sodium ascorbate and 10 mM HEPES. The plated
cells werewashedwith freshmedium thenext day and replenished cul-
ture medium every second day. Mouse NIH3T3 and C2H10T1/2 cells
were cultured in DMEM (Invitrogen) supplemented with 10% fetal bo-
vine serum (FBS) (Invitrogen). To induce adipogenesis, primary adipo-
cytes were cultured in the medium supplemented with 5 μM
dexamethasone, 0.02 μM insulin, 0.5 mM isobutylmethylxanthine,
1 nM T3, 125 μM indomethacin, and 1 μM rosiglitazone. Forty-eighthours after induction, cells were cultured in DMEM supplemented
with 0.02 μM insulin and 1 nM T3 which mediated the differentiation
of primary adipocytes. Differentiation of NIH3T3 and C3H10T1/2 cells
was conducted by culturing the cells in inductionmedium supplement-
ed with 20% FBS, 0.5 mM IBMX, 12.7 μMdexamethasone, and 10 μg/ml
insulin. Forty-eight hours after induction, the inductionmediumwas re-
placed with differentiation medium (DM) supplemented with 10% FBS
and 10 μg/ml insulin and replenished every 2 days.
2.3. Plasmid construction, transfection and RT-PCR analysis
Expression vectors for mouse RBM4a isoforms were constructed by
placing the coding sequence in-frame into pCDNA3.1-FLAG (Invitrogen).
Expressing vectors containing a mutated RNA recognition motif or zinc
knuckle domain of RBM4a were constructed using the QuikChange site-
directed mutagenesis system (Stratagene). The phRbm4a minigene
reporter was constructed by sequential insertion of two human Rbm4a
genomic fragments into the pCH110 vector (Amersham Pharmacia).
The Rbm4a fragments were as follows: 3738-bp exon 2–intron 2
(nucleotides 66407183–66410920) and 2617-bp exon 3–exon 4
(66410921–66413537; NM_002896). NIH3T3 and C3H10T1/2 cells
were grown to 50%–60% conﬂuence and transfected using PolyJet
(SignaGen) with the indicated plasmid. After 24 h, total RNA was ex-
tracted using the TRIzol reagent (Invitrogen). For RT-PCR assay, 2 μg
of RNA was reverse-transcribed by SuperScriptase III (Invitrogen) in a
10-μl reaction. The PCR analysis of individual genes was performed in
30 (Gapdh) or 35 thermal cycles (other genes) with gene-speciﬁc
primer sets (see Table S1). A quantitative RT-PCR was performed with
SYBR green ﬂuorescent dye and gene-speciﬁc primer sets (see
Table S2) using an ABI One Step™ PCR machine (Applied Biosystems).
The relative mRNA level was quantitated by the ΔΔ−Ct method, and
the level of GapdhmRNA served as the internal control.
2.4. Immunoblotting and subcellular fractionation
Immunoblotting of cell lysates or tissue extracts was performed
using an enhanced chemiluminescence system (PerkinElmer). Images
were analyzed by the LAS-4000 imaging system (Fujiﬁlm). The primary
antibodies applied in this study included polyclonal antibodies against
RBM4 [7], insulin receptor (Santa Cruz), lamin (Santa Cruz), and p38
MAPK (Cell Signaling), andmonoclonal antibodies against the FLAG epi-
tope (M2, Sigma-Aldrich), tubulin (Thermo Fisher Scientiﬁc), and phos-
phorylated p38 MAPK (Cell Signaling Technology). For a subcellular
fractionation analysis, cells were resuspended in 500 ml of RSB-100
(10 mM Tris–HCl, 100 mM NaCl, and 2.5 mMMgCl2; pH 7.4) contain-
ing 40 mg/ml digitonin (Calbiochem). After incubation on ice for
5 min, cells were centrifuged at 2000 g for 8 min. The supernatant
was collected as the cytosolic fraction, and the pellet was resuspended
in 500 ml of RSB-100 containing 0.5% Triton X-100 for a further 5-min
incubation on ice. After centrifugation at 2000 g for 8 min, the superna-
tant was collected as the nuclear fraction.
2.5. Immunoﬂuorescence
Indirect immunoﬂuorescencewas performed as described previous-
ly [30]. Primary antibodies used in this studywere polyclonal antibodies
against RBM4 and monoclonal antibodies against the FLAG epitope
(20 μg/ml; Sigma). Secondary antibodies were used as described previ-
ously [7]. Imageswere observedusing the TE2000-Umicroscopy system
(Nikon).
2.6. Oil-Red-O staining
Proliferating and differentiating cells were washed twice with
phosphate-buffered saline (PBS) and ﬁxed with 4% paraformaldehyde
for 60 min at room temperature. Cells were washed with PBS twice
Fig. 1. Rbm4a−/−mice exhibit hyperlipidemia and impaired brown adipose tissue (BAT) development. Eight-week oldwild-type (WT) and Rbm4a−/−malemicewere subjected to the following examinations. (A) Serum triglyceride of fastingmice is
quantiﬁed (WT, 82.83 mg/dl ± 11.3 mg/dl, n = 6; Rbm4a−/−, 131 ± 19.12 mg/dl, n = 6; ***, p b 0.005). (B) Interscapular BAT isolated fromWT and Rbm4a−/−mice were weighted and normalized to the bodyweight (n = 6; ***, p b 0.005). (C)
Interscapular white adipose tissue (WAT) isolated from mice were weighted and normalized to the body weight (n = 6; ***, p b 0.005). (D) Total RNA isolated from the iBAT and iWAT was subjected to RT-PCR using speciﬁc primer sets (see
Table S1). Total lysates of isolated BAT and WAT were subjected to immunoblotting analysis using indicated antibodies. (E) mRNA level of each factor in interscapular brown and white adipose tissues was quantiﬁed by quantitative RT-PCR
(qRT-PCR) using speciﬁc primer sets (right panel; see Table S2). Glyceraldehyde 3 phosphate dehydrogenase (Gapdh) mRNA served as a loading control.
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Fig. 2. Expression of RBM4a and adipocyte-related factors in differentiating adipocyte. Primary interscapular brown and white adipocytes (iBA and iWA) were cultured in differentiation
medium (DM) for 7 and 14 days. Total RNAwas isolated and then subjected to RT-PCR analysiswith speciﬁc primer sets (see Table S1). Gapdh served as a loading control. Cell lysateswere
fractionated on separate gels, followed by immunoblotting with the indicated antibodies.
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ibrated cells were stained with a 0.3% ﬁltered Oil-Red-O solution
(Sigma) for 10 min at room temperature. Stained cells were washed
with distilled water for 3 times. For extraction of Oil-Red-O dye, the cul-
ture dish with absolute isopropanol was shaken at room temperature
for 2 h. The extract was centrifuged and analyzed at 550 nm using a
NanoDrop 2000 spectrophotometer (Thermo).
2.7. Mitochondria respiration assay
A Seahorse XF24 extracellular ﬂux analyzer (Seahorse Bioscience,
North Billerica, MA, USA)was used tomeasure the oxygen consumption
rate (OCR; as an indicator of mitochondrial respiration). In brief, 50,000
preadipocytes or C3H10T1/2 cells were seeded in each well of Seahorse
XF24 plates with 150 μl of DMEM and incubated overnight. Prior to the
measurement, cellswerewashedwith unbufferedmedia and immersed
in 675 μl unbuffered media without CO2 for 1 h. The OCR was assessed
in 8-min cycles as recommended by Seahorse Bioscience. The basal OCR
level was recorded ﬁrst, and following injection of FCCP, the maximal
OCR was revealed.
3. Results
3.1. Rbm4a−/−mice exhibit hyperlipidemia and impaired BAT development
In mice, there are two copies of the Rbm4 gene (namely Rbm4a
and Rbm4b) adjacent to each other on the same chromosome [11].
Rbm4a−/−mice exhibited defective production of insulin,which resulted
in signiﬁcant hyperglycemia [11]. The close relation between hypergly-
cemia and hyperlipidemia prompted the investigation into the impact
of high glucose on TG metabolism in Rbm4a−/−mice [31]. Biochemical
analysis showed that starved wild-type mice exhibited normal level of
serum TG (Fig. 1A, 82.83 mg/dl [n = 6]), whereas the elevated TG
level was examined in Rbm4a−/− mice (131 mg/dl [n = 6]). In addi-
tion, high glucose was considered as the adipogenic inducer [32] andwe therefore examined the impact of hyperglycemia on the develop-
ment of adipose tissue in Rbm4a−/−mice. About 50% reduction in the
interscapular BAT (iBAT) mass and 15% reduction in the interscapular
WAT (iWAT) mass was noted in Rbm4a−/− adult mice as compared to
the wild-type littermates (Fig. 1B and C).
The relatively prominent expression of RBM4a over RBM4b in iBAT
as compared with iWAT once again implied the inﬂuence of RBM4a on
BAT development (Fig. 1D, lower panel and Fig. S1). We next asked
whether depletion of RBM4a affected the development of BAT. As
shown by RT-PCR analysis, ablation of Rbm4a increased the level of
exon 11-skipped insulin receptor (IR) isoform in adult iBAT (Fig. 1D,
lane 4) as was shown in Rbm4a-depleted muscle and pancreatic cells
[10,11]. The impaired expression of BAT-speciﬁc markers (Myf5, Bmp7,
Prdm16 and Ucp1) was also noted in the Rbm4a−/− BAT (Fig. 1D, lanes
2 and 4). A growing body of evidence has demonstrated the action of
Myf5 on committing myoblastic lineages including the skeletal muscle
and brown adipocytes [15,16]. In addition, upregulated BMP7 and
PRDM16 were also shown to commit the complete development of
brown adipocytes [26]. The results indicated the defective development
of Rbm4a-depleted iBAT in the prenatal and postnatal stages. On
the other hand, the reduced level of WAT-speciﬁc markers
(Angiotensinogen, Resistin) and brite cell markers (Cited1 and Hoxa9)
in Rbm4a−/− iWAT suggested the potential effect of RBM4a onWAT de-
velopment and white-to-brown trans-differentiation of adipocytes
(Fig. 1D, lanes 6 and 8). The expression proﬁle of adipocyte-related
genes in Rbm4a−/− adipose tissues and their counterparts was further
quantiﬁed using Quantitative RT-PCR (qRT-PCR, Fig. 1E). These results
showed the wide impact of RBM4a ablation on the development of dis-
tinct adipocytes.
3.2. Expression of RBM4a and adipocyte-related factors during adipogenesis
We next wondered whether the expression of RBM4a protein was
modulated during adipocyte differentiation. Increase in the BAT-
speciﬁc Ucp1 (Fig. 2, lanes 2 and 3) and WAT-speciﬁc Ang transcript
Fig. 3.Ablation of RBM4a impairs the adipocyte differentiation. (A) Primary preadipocytes isolated from the iBAT ofwild-type and Rbm4a−/−micewere cultured in growthmedium (GM)
orDMfor 7 days. Themock vector-transfectedC3H10T1/2 cellswere cultured inGMorDMfor 7 days; the FLAG-RBM4avector-transfected cellswere cultured inGMand then subjected to
the Oil-Red-O staining. (B) The bar graph showed the spectrophotometric analysis of Oil-Red-O optical density (OD) at 550 nm after being extracted from the stained cells in previous
experiments (*, p b 0.05; **, p b 0.01; ***, p b 0.005). (C) The RNA was extracted fromWT and Rbm4a−/− preadipocytes (iBA/iWA) cultured in GM or DM for 7 days and subjected to
the RT-PCR analysis using speciﬁc primer sets. (D) Graphs presented the oxygen consumption rate (OCR) of proliferation and differentiation WT and Rbm4a−/− iBA toward FCCP treat-
ment. Values shown were the mean ± SEM of three individual experiments for each group (***, p b 0.005).
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brown andwhite adipocytes (iBA and iWA) [33,34]. RT-PCR and immu-
noblotting assay showed a gradual increase in Rbm4a transcript and
proteinwhich resulted in the upregulated IR-B isoform in differentiating
primary adipocytes. The gradual increase in IR-B subsequently induced
the hyperphosphorylation of p38 MAPK which was essential to the de-
velopment of brown adipocytes rather than white adipocytes
[11,19,35]. The results showed that RBM4a could act as an effector in
adipogenesis-required signaling pathway.
3.3. RBM4a−/− preadipocytes exhibit impaired differentiation
The primary adipocytes isolated from RBM4a−/− iBAT andwild type
iBAT were established to evaluate the inﬂuence of RBM4a on adipogen-
esis. Oil-Red-O staining showed that less lipid droplet were noted in
differentiating RBM4a−/− iBA (Fig. 3A, middle, DM) as compared with
its wild-type littermates (Fig. 3A, upper, DM). Inversely, RBM4a-
overexpressed C3H10T1/2 cells exhibited the lipid droplet accumula-
tion aswas seen in differentiating cells (Fig. 3A, lower). The effect of dif-
ferentiation condition and RBM4a overexpression on adipogenesis was
quantitatively evaluated in terms of the extracted Oil-Red-O usingspectrophotometric analysis (Fig. 3B). Rbm4a−/− adipocytes exhibited
insigniﬁcant induction of adipocyte-speciﬁc markers toward differenti-
ation condition, which indicated its impaired differentiation (Fig. 3C,
lanes 4 and 8). Besides the cell differentiation, the downregulated
Ucp1 suggested the altered energetics in the RBM4a−/− adipocytes.
The reserve capacity of mitochondria was measured in the presence of
the electron transport uncoupler FCCP (0.5 μM) to verify this hypothe-
sis. No signiﬁcant difference in the basic respiratory rate was noted be-
tween the proliferating wild-type and RBM4a−/− brown adipocytes
(Fig. 3D,white and downward bar). Nevertheless, the oxygen consump-
tion rate of differentiating RBM4a−/− iBA was lower (black bar) than
those of wild-type iBA (gray bar) in the presence of FCCP, which sug-
gested the impaired energy expenditure in RBM4a−/− adipocytes. The
results suggested that ablation of RBM4a abolished not only the devel-
opment but also the physiological function of brown adipocytes.
3.4. RBM4a enhances adipocyte differentiation
The shift in the alternative splicing of Pref-1 genewas demonstrated
to relieve its repressive effect on adipogenesis and in turn commit the
pre-adipocytes to terminal differentiation [29]. The signiﬁcant shift in
Fig. 4. RBM4a promotes the adipocytic transcription network. (A) NIH3T3 cells were cultured in GM or DM for 14 days. Total RNA was extracted and subjected to RT-PCR using speciﬁc
primer pairs as indicated. (B) NIH3T3 cells were transiently transfectedwith themock vector, or the FLAG-RBM4a-expressing vector or the RBM4a-targeting shRNA expressing vector and
cultured in GM for 24 h. RT-PCR analysis was performed as described for panel A. (C) mRNA level of each factor in NIH3T3 (left three panels) and C3H10T1/2 cells (right three panels)
cultured under the indicated conditions was quantiﬁed by qRT-PCR using speciﬁc primer set (see Table S2). The bar graph showed the results from three independent experiments.
Total cell lysate isolated fromNIH3T3 and C3H10T1/2 cells was subjected to immunoblotting assay using indicated antibodies. (D) Graphs presented the oxygen consumption rate of pro-
liferation, differentiation and RBM4a overexpressing C3H10T1/2 cells toward FCCP treatment. Values shown were the mean ± SEM of three individual experiments for each group
(***, p b 0.005).
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RBM4-overexpressed NIH3T3 cells (Fig. 4B) which exhibited upregulat-
ed WAT-speciﬁc markers, whereas the knockdown of endogenous
RBM4a led to the expression of adipocyte-speciﬁc factors (Fig. 4B,
shRBM4a). The presence of overexpressed RBM4a also resulted in the
decrease in Ppar-γ1 concomitant with an increased level of Ppar-γ2,
which represented another adipocyte-speciﬁc splicing event (Fig. 4A
and B). The parallel experiments were conducted with the BAT-like lin-
eage, C3H10T1/2 cells [26,36] to speciﬁcally evaluate the effect of
RBM4a on brown adipocytes. The similar trend to the expression of
adipocyte-speciﬁc markers was showed in the RBM4a-overexpressed
C3H10T1/2 as was seen in NIH3T3cells (Fig. 4C, lower panel). However,
the signiﬁcant response of BAT-speciﬁc factors were only noted in the
differentiating C3H10T1/2 cells (Fig. 4C, upper panel, BAT), but not the
NIH3T3 cells. Besides the upregulation of adipocyte-speciﬁc factors,
the RBM4a-overexpressed C3H10T1/2 cells exhibited the elevated
oxygen consumption rate toward FCCP treatment, which illustrated
the inﬂuence of RBM4aon the function of BAT (Fig. 4D, RBM4). These re-
sults revealed the effect of RBM4a overexpression on enhancing the dif-
ferentiation and function of BAT-like lineage, which echoed to the
impaired development of Rbm4a−/− interscapular BAT (Figs. 1D and
3D).3.5. RBM4a autoregulates its expression by directing alternative splicing
The increase in RBM4a protein has been noted during the differenti-
ation of distinct cells [10,11], themechanism involved in this regulation
has not been addressed. Notably, a search of the NCBI EST database re-
vealed an alternatively-spliced isoform of Rbm4a in small rodents. We
wondered whether the isoform shift in Rbm4a transcript participated
in the regulation of its protein level. The endogenous Rbm4a isoforms
were ampliﬁed using the PCR primers which speciﬁcally targeted the
conserved exon 2 and the 3′ untranslated region (UTR) of the Rbm4a
transcript (Fig. 5A). The relatively high level of full-length transcript
(Fig. 5B, upper panel) correspondedwith the quantity of RBM4a protein
in the skeletal muscle, testis and kidney (Fig. 5B, lower panel, lanes 2, 3
and 6). By contrast, the exon 3-skipped isoform (Rbm4a-iso2) was pre-
dominantly expressed in the liver, placenta, bone marrow and adrenal
gland, of which the RBM4a protein was nearly absent (Fig. 5B, lanes 4,
5, 7 and 8). Nevertheless, the lower amount of canonical Rbm4a tran-
script concomitant with a relatively high level of RBM4a protein in the
heart implied that additional post-transcriptional eventmay participate
in regulating RBM4a expression. The Rbm4a full-length transcript was
also elevated in differentiating cells, which corresponded with the in-
crease in RBM4a protein (Fig. 5C).
Fig. 5. Rbm4a transcripts are alternatively spliced. (A) The diagrams show twomouse Rbm4a isoforms that were identiﬁedwith speciﬁc primer set. Schematic representation indicates the
domains of mouse RBM4a isoforms. (B) Total RNA and the tissue extract were isolated from differentmouse tissues and subjected to RT-PCR and immunoblotting analysis using a speciﬁc
primer set and antibody against Rbm4a. The values given below the bands represent relative levels of the full length Rbm4a isoform over all Rbm4a transcripts. (C) Total RNA and cell lysate
isolated from proliferation or differentiation NIH3T3 cells were subjected to RT-PCR and immunoblotting analysis using a speciﬁc primer set and antibody against Rbm4a. (D) NIH3T3 cells
were transiently transfectedwith themock vector or vector expressingwild-type or various RBM4amutants. The overexpressed-protein level and splicing proﬁle of Rbm4a isoformswere
analyzed as described for panel A. Values given below the bands represented relativemRNA level of full length Rbm4a transcript. (E) Diagram illustrates theRbm4aminigene construct and
the checkered box represents the SV40 promoter. The pCH-hRbm4aminigene was cotransfected with RBM4a-expressing vectors in NIH3T3 cells. The splicing products were analyzed by
RT-PCR using primer set as shown in Table S1.
775J.-C. Lin et al. / Biochimica et Biophysica Acta 1843 (2014) 769–779To investigate whether RBM4a modulated the splicing of its own
transcript, the splicing pattern of endogenous Rbm4a transcript was an-
alyzedwith the reverse primer targeting the3′UTRwhich is absent from
the RBM4a expression vector. The full-length Rbm4a transcript was
markedly elevated in the presence of exogenous wild-type RBM4a
(Fig. 5D, lane 2) but not RBM4a-Iso2 or other engineered mutants
(lanes 3–5). The Rbm4aminigene vector, pCH-Rbm4a, which contained
the complete genomic segment from exon 2 to the 3′UTRwas next con-
structed to verify the effect of RBM4a on the splicing of its own tran-
script (Fig. 5E, upper panel). RT-PCR analysis showed the signiﬁcant
increase in the full-length Rbm4a analog in the presence of differentia-
tion medium, wild-type FLAG-RBM4a and the zinc knuckle mutant
(Fig. 5E, lanes 2, 4 and 6). On the contrary, the exon 3-skipped isoform
was noted in the presence of mutated RRM-harboring RBM4a and
RBM4a-Iso2 (lanes 5 and 7). An analogous result also showed the loss
of the canonical Rbm4a transcript in the Rbm4b−/− BAT (Fig. S2).
These results suggested that the canonical RBM4a constituted a
feedforward circuit which autoregulated the selection of exon 3 within
its own transcript.3.6. RBM4a-Iso2 antagonizes the autoregulatory mechanism
The ubiquitously high level of Rbm4a-iso2 isoform prompted the fol-
lowing investigation into its effect on the expression of full-length
RBM4a. As shown in Fig. 6, the presence of exogenous RBM4a-Iso2
abolished the exon 3 inclusion of endogenous Rbm4a in a dose-
dependent manner (Fig. 6B, left panel), which resulted in the reduced
level of endogenous RBM4a protein (Fig. 6A). Moreover, the exogenous
RBM4a-Iso2 antagonized the effect of canonical RBM4a with regard to
the isoform shift in IR and Ppar-γ genes and the upregulation of
adipocyte-speciﬁc factors (Fig. 6B, right panel; Fig. 6C).
Majority of endogenous RBM4a was shown to distribute in the nu-
cleus of proliferating NIH3T3 cells (Fig. 6D, upper panel, GM), but
translocated to the cytoplasm of differentiating cells (Fig. 6D, upper
panel, DM). On the contrary, exogenous RBM4-Iso2 not only showed
the steady distribution in the cytoplasm of proliferating and differenti-
ating cells (Fig. 6D, upper panel, FLAG-Iso2), but also directed the cyto-
plasmic localization of endogenous RBM4a protein in proliferating cells
(Fig. 6D, right panel). Subcellular fractionation showed the similar
Fig. 6. Expression of RBM4a is autoregulated via alternative splicing. (A) NIH3T3 cells were transfected with the mock vector or the vector expressing FLAG-RBM4 isoform 2 (Iso2). Im-
munoblotting was performed on the samemembranes (separated by a blank space) using indicated antibodies. (B) The FLAG-RBM4a expression vector was transfected alone (lane 2) or
with increasing amounts of the FLAG-RBM4a Iso2 expression vector (lanes 3 and 4) to NIH3T3 cells. Splicing proﬁle of Rbm4a and the level of adipose-related factors were assayed by RT-
PCR as previously described. FLAG-tagged proteins were examined by immunoblotting with anti-FLAG antibody. (C) mRNA level of adipose-related factors in parallel experiments was
quantiﬁed using qRT-PCR with speciﬁc primer sets as previously described. (D) The mock vector or FLAG-RBM4a Iso2-overexpressed NIH3T3 cells were cultured in growth medium
(GM) or differentiationmedium (DM) for 7 days and then subjected to immunoﬂuorescence assay using indicated antibodies. The lower panel showed the subcellular distribution of en-
dogenous RBM4a and the FLAG-tagged Iso2 variant (right) in proliferating or differentiating NIH3T3 cells using anti-RBM4 or anti-FLAG antibody; Laminwas used as a loading control. (E)
Total cell extracts were prepared from mock vector or FLAG-RBM4a Iso2-transfected NIH3T3 cells grown in GM and subjected to anti-FLAG immunoprecipitation followed by immuno-
blotting assay.
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entiating and RBM4a-Iso2 overexpressed cells (Fig. 6D; lower panel,
lanes 4 and 8). The colocalized distribution of RBM4a isoforms in prolif-
erating cells (Fig. 6D, right) and the result of immunoprecipitation anal-
ysis demonstrated the association between RBM4a isoforms in vivo
(Fig. 6E, lane 4). These results suggested that the interplay between
RBM4a isoforms could disturb the cellular distribution of canonical
RBM4a, which in turn ﬁne-tuned its effect on splicing regulation.
3.7. RBM4a regulates adipogenesis through multiple mechanisms
RBM4a has been demonstrated to affect the expression of multiple
pancreas-speciﬁc factors in a alternative splicing-mediated regulation
[11] or through uncertain mechanism. Nevertheless, the existence in
RBM4a of a zinc knuckle (CCHC) motif implied the putative action of
RBM4a on transcriptional regulation. RT-PCR analysis showed that the
mutant and deletion of RNA recognition motif abolished the effect of
RBM4a on the splicing of IR and Ppar-γ and induced expression of
Bmp2, Pgc1α and Ucp1 (Fig. 7A, mRRM and Iso2). By contrast, the mu-
tant and absence of zinc knuckle motif largely impaired the inﬂuenceof RBM4a on Bmp7 and Prdm16 expression (Fig. 7A,mZn and Iso2). Con-
spicuously, the expression ofMyf5 showedno response only to the pres-
ence RBM4a-Iso2 in preadipocytes. The inﬂuence of exogenous RBM4
proteins on the expression proﬁle of adipocyte-speciﬁc factors differed
from the biological activity, but not the expression level in transfected
cells (Fig. 5D, lower panel). qRT-PCR assay showed the similar trend to
the expression of adipocyte-speciﬁc markers as was noted using RT-
PCR analysis (Fig. 7B). These results suggested that RBM4a may modu-
late the expression of adipocyte-related factors through posttranscrip-
tional regulation and transcriptional control.
4. Discussion
Classical brown adipocytes are demonstrated to originate from
Myf5-positive progenitors in the prenatal stage [15,16] whereas the
beige/brite cells arise from Myf5-negative lineage in response to cold
stress or PPARγ agonists in the postnatal stage [17]. Nevertheless, the
mechanism involved in the development of beige/brite cells is still poor-
ly understood. Drastic elimination ofMyf5 in the embryonic Rbm4a−/−
BAT rather than adult BAT (Fig. 1D, lanes 2 and 4) suggested its critical
Fig. 7. RBM4a modulates BAT development through distinct mechanisms. (A) NIH3T3 cells were transiently transfected with the mock vector or the expression vectors encode various
RBM4a proteins. Splicing proﬁle of IR and the level of adipose-related factors were assayed by RT-PCR as previously described. (B) mRNA level of adipose-related factors in parallel exper-
iment was quantiﬁed using qRT-PCR with speciﬁc primer sets.
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of Rbm4a−/− iBA indicated the action of RBM4a on the physiological
function of iBA. The diminished Cited1 and Hoxa9 expression in adult
Rbm4a−/− adipose tissues rather than embryonic adipocytes (Fig. 1D,
lanes 4 and 8) implied the inﬂuence of RBM4a on the white-to-brown
trans-differentiation of adipocytes. This speculationwas initially proved
with the upregulation of the BAT-speciﬁc markers in theWAT-like line-
age which expressed exogenous RBM4a (Fig. 4B). On the other hand,
the action of RBM4a on white adipocyte-speciﬁc factors still suggestedFig. 8. RBM4a modulated the splicing proﬁle of IR, Pref-1, Ppar-γ and its own transcript
during adipogenesis. RBM4a expression was autoregulated through the alternative splic-
ing mechanism. Inhibition of adipocyte differentiation was relieved in the presence of
RBM4a-increased Pref-1D isoform. RBM4-induced PPARγ2 in turn activated the
adipocyte-speciﬁc transcription network. The increase in RBM4a induced IR-B expression,
subsequently activating the downstream p38 MAPK signaling which was required for the
development of BAT.its potential effect on the development of WAT-like lineage, which ech-
oed to the reduced iWATmass in Rbm4a−/−mice. The signiﬁcant inﬂu-
ence of RBM4a on the classical brown adipocytes and brite cells may
explain why Rbm4a−/−mice exhibited a triﬂing reduction inWAT con-
comitant with a signiﬁcant loss in BAT mass.
Continuous studies illustrated how splicing factors reprogrammed
the splicing proﬁle which determined the cell fate and function. For in-
stance, two Nova genes were demonstrated to regulate more than 700
neuron-speciﬁc splicing events [37]. CELF family members regulated
themuscle-speciﬁc splicing network which greatly inﬂuenced myocyte
development and function [38]. RBM4 was demonstrated to promote
the complete development of the skeletal muscle and pancreatic islets
by means of reprogramming the tissue-speciﬁc splicing network
[10,11]. IR gene is alternatively spliced to encode the exon 11-
excluded IR-A and exon 11-included IR-B isoforms [39]. An increase in
IR-A expression activated insulin growth factor (IGF) signaling which
largely contributed to the proliferation of preadipocytes in the prenatal
stage, whereas upregulated IR-B isoform activated insulin signaling
which directed the development of adult adipocytes [40]. A marked
shift from isoform IR-A to IR-B has been noted during the differentiation
of progenitors to brown adipocytes [33]. However, supplementation
with either IR isoform failed to commit the differentiation of IR-
ablated brown preadipocytes [33]. Furthermore, excess IR expression
was associatedwith an inability to undergo adipogenesis [33], implying
that elevated IR abundancemay impair the IGF-IR signaling by compet-
ing with downstream signaling pathways [41]. These results indicated
that the meticulous modulation of IR isoforms played a pivotal role in
adipocyte differentiation. The CTG-expanded dmpk transcriptmediated
the nuclear accumulation of CUG-binding protein 1 and hnRNP H pro-
tein, which in turn antagonized the effect of muscleblind 1 protein on
promoting IR-B production in the skeletal muscles of patients with
myotonic dystrophy type 1 [42–46]. These results illustrated that the
splicing of IR pre-mRNA was regulated by the balance between various
splicing factors, which severely inﬂuenced the fate and function of spe-
ciﬁc cells. In this study, RBM4 was demonstrated to increased the
778 J.-C. Lin et al. / Biochimica et Biophysica Acta 1843 (2014) 769–779relative level of IR-B which is required for complete differentiation of
brown adipocytes.
Alternative splicing was considered as a regulatory mechanism in
ﬁne-tuning the activity of transcriptional factors. Pref-1 served as a
dominant repressor at the onset of adipocyte differentiation [47]. The
repressive effect of Pref-1 on adipogenesis was attenuated through
both transcriptional regulation [48] and alternative splicing events
[29]. In this study, RBM4a was demonstrated as the ﬁrst splicing factor
which reprogrammed the splicing pattern of Pref-1 (Fig. 4B). On the
other hand, the ubiquitously expressed PPAR-γ1 was reported to
enhance the development of adipocytes embedded in the liver, whereas
PPAR-γ2 speciﬁcally regulated the development of interscapular
adipose tissues [49,50]. RBM4was revealed as theﬁrst splicing regulator
whichmodulated the isoform shift of Ppar-γ during adipogenesis. These
results indicated that RBM4 could reprogram the adipocyte-speciﬁc
splicing network which in turn regulated adipocyte development.
The spatiotemporal balance between various splicing factors deter-
mined the splicing proﬁle in particular cell types and developmental
stages. Hence, the expression of splicing factors must be meticulously
controlled. Negative autoregulationwasdemonstrated to be an effective
mechanism for maintaining the precise level of many splicing factors.
For example, Tra-2 SR proteins, including SRp20, SC35 and ASF,
autoregulated the splicing patterns of their respective transcripts
[51–54]. The expression of mammalian PTB and SC35 protein was neg-
atively autoregulated by producing premature termination codon-
containing pre-mRNA which was subsequently degraded by the
nonsense-mediated decay pathway [54,55]. Excess SRp20 directed a
negative-control mechanism by favoring the expression of an exon 4-
skipping SRp20 isoform [51]. In this study, the increase in canonical
RBM4a established a feed-forward circuit by increasing the relative
ratio of its canonical isoform. However, upregulated RBM4a may inter-
ferewith the interaction between its transcript and other splicing factor,
such as PTB which served as the antagonizer to the RBM4a-regulated
splicing event [10]. Nevertheless, the isoform shift of RBM4a transcripts
sheds new light on a positive-control mechanism by which the expres-
sion of RBM4a was manipulated.
In conclusion, our results showed that RBM4a promoted the devel-
opment of brown adipocytes by integrating the splicing regulation
and transcriptional control in distinct stages of adipogenesis (Fig. 8).
Moreover, the feed-forward mechanism was ﬁrst constituted, which
contributed to the autoregulation of RBM4a in differentiating adipo-
cytes. We propose that the effect of RBM4a on the development and
function of BAT may suggest its therapeutic potential for combating
metabolic diseases and obesity.
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